关注
Alicia Tosoni
Alicia Tosoni
Oncologia medica Bellaria Hospital Bologna Italy
在 ausl.bo.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
MGMT Promoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed …
AA Brandes, E Franceschi, A Tosoni, V Blatt, A Pession, G Tallini, ...
Journal of Clinical Oncology 26 (13), 2192-2197, 2008
9812008
Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034
MJ van den Bent, AA Brandes, R Rampling, MCM Kouwenhoven, JM Kros, ...
Journal of Clinical Oncology 27 (8), 1268-1274, 2009
6392009
Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation with MGMT promoter methylation status
AA Brandes, A Tosoni, E Franceschi, G Sotti, G Frezza, P Amistà, ...
Journal of Clinical Oncology 27 (8), 1275-1279, 2009
3872009
Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: pitfalls in neurooncology
AA Brandes, A Tosoni, F Spagnolli, G Frezza, M Leonardi, F Calbucci, ...
Neuro-oncology 10 (3), 361-367, 2008
3422008
Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO)
AA Brandes, A Tosoni, G Cavallo, R Bertorelle, V Gioia, E Franceschi, ...
British journal of cancer 95 (9), 1155-1160, 2006
2802006
Glioblastoma in adults
AA Brandes, A Tosoni, E Franceschi, M Reni, G Gatta, C Vecht
Critical reviews in oncology/hematology 67 (2), 139-152, 2008
2662008
Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status
AA Brandes, E Franceschi, A Tosoni, F Benevento, L Scopece, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2009
2582009
Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection
C Agostini, F Calabrese, F Rea, M Facco, A Tosoni, M Loy, G Binotto, ...
The American journal of pathology 158 (5), 1703-1711, 2001
2562001
Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
E Franceschi, G Cavallo, S Lonardi, E Magrini, A Tosoni, D Grosso, ...
British journal of cancer 96 (7), 1047-1051, 2007
2342007
Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent …
AA Brandes, A Tosoni, G Cavallo, M Reni, E Franceschi, L Bonaldi, ...
Journal of clinical oncology 24 (29), 4746-4753, 2006
2212006
Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas
L Trentin, A Cabrelle, M Facco, D Carollo, M Miorin, A Tosoni, P Pizzo, ...
Blood 104 (2), 502-508, 2004
1972004
The pathogenesis and treatment of brain metastases: a comprehensive review
A Tosoni, M Ermani, AA Brandes
Critical reviews in oncology/hematology 52 (3), 199-215, 2004
1922004
Long‐term results of a prospective study on the treatment of medulloblastoma in adults
AA Brandes, E Franceschi, A Tosoni, V Blatt, M Ermani
Cancer 110 (9), 2035-2041, 2007
1732007
How effective is BCNU in recurrent glioblastoma in the modern era? A phase II trial
AA Brandes, A Tosoni, P Amista, L Nicolardi, D Grosso, F Berti, M Ermani
Neurology 63 (7), 1281-1284, 2004
1702004
Epidermal growth factor receptor inhibitors in neuro-oncology: hopes and disappointments
AA Brandes, E Franceschi, A Tosoni, ME Hegi, R Stupp
Clinical cancer research 14 (4), 957-960, 2008
1662008
First-line chemotherapy with cisplatin plus fractionated temozolomide in recurrent glioblastoma multiforme: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia
AA Brandes, U Basso, M Reni, F Vastola, A Tosoni, G Cavallo, L Scopece, ...
Journal of Clinical Oncology 22 (9), 1598-1604, 2004
1452004
Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo …
AA Brandes, A Tosoni, U Basso, M Reni, F Valduga, S Monfardini, ...
Journal of clinical oncology 22 (23), 4779-4786, 2004
1432004
O6-methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for …
AA Brandes, E Franceschi, A Tosoni, S Bartolini, A Bacci, R Agati, ...
Neuro-oncology 12 (3), 283-288, 2010
1422010
Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I–III
M Visani, D De Biase, G Marucci, S Cerasoli, E Nigrisoli, MLB Reggiani, ...
Molecular oncology 8 (2), 417-430, 2014
1162014
Dose‐dense temozolomide regimens: Antitumor activity, toxicity, and immunomodulatory effects
B Neyns, A Tosoni, WJ Hwu, DA Reardon
Cancer 116 (12), 2868-2877, 2010
1132010
系统目前无法执行此操作,请稍后再试。
文章 1–20